Know Cancer

or
forgot password


Phase 2
17 Years
75 Years
Not Enrolling
Both
Biliary Tract Cancer

Thank you

Trial Information


Inclusion Criteria:



- Histologically or cytologically confirmed inoperable biliary tract cancer

- Age: 18 ~75 years old

- Performance status: ECOG 0-2

- Hematopoietic:

- Granulocyte count at least 1,500/mm3

- Platelet count at least 100,000/mm3

- Hepatic:

- Bilirubin No greater than 2 fold the upper normal limit

- AST/ALT : No greater than 3 fold the upper normal limit

- Renal:

- Creatinine - no greater than 1.5 mg/dL

- Not pregnant

- No other serious medical or psychiatric illness that would preclude giving informed
consent or limit

- No prior chemotherapy within 6 months

- No other concurrent anticancer radiotherapy within 6 months

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Principal Investigator

Jeong Youp Park, MD

Investigator Role:

Study Director

Investigator Affiliation:

Assistant professor of division of Gastroenterology

Authority:

Korea: Food and Drug Administration

Study ID:

4-2007-0191

NCT ID:

NCT00832689

Start Date:

June 2008

Completion Date:

March 2010

Related Keywords:

  • Biliary Tract Cancer
  • toxicity
  • Biliary Tract Neoplasms

Name

Location